Literature DB >> 8033323

Preferential formation and repair of chromium-induced DNA adducts and DNA--protein crosslinks in nuclear matrix DNA.

J Xu1, F C Manning, S R Patierno.   

Abstract

The distributions of chromium-DNA adducts and DNA-protein crosslinks induced by treatment of intact CHO cells with carcinogenic chromium were examined in distinct chromatin subfractions: a chromatin subfraction released by digestion of isolated nuclei with micrococcal nuclease (1SF, 14% of total nuclear DNA), bulk chromatin (74% of total DNA) and a nuclear matrix fraction (12% of total DNA). The identity of the matrix fraction was confirmed by hybridization of DNA from each subfraction with a cDNA probe prepared from total mRNA isolated from CHO cells, which showed that the 1SF and nuclear matrix fractions were 2.3- and 3.8-fold enriched in actively transcribed genes respectively, compared to total unfractionated DNA. Immediately following treatment of cells with 150 microM sodium chromate for 2 h the binding of chromium to each chromatin fraction was found to be non-uniform. Compared with total unfractionated nuclei, the nuclear matrix fractions were enriched in chromatin-bound chromium (3.4-fold), whereas the bulk chromatin fraction was relatively depleted (0.5-fold). Approximately 13% of nuclear chromium was associated with the detergent-soluble lipid component of nuclei. A similar distribution of chromatin-bound chromium was also apparent 24 h after the chromate treatment. Immediately after the 2 h chromate treatment, chromium-DNA adducts were detected in all the chromatin subfractions. Total nuclear and bulk chromatin DNA contained similar levels of this type of damage. The 1SF fraction was depleted approximately 3-fold in this type of damage compared with total nuclear DNA. In contrast, the nuclear matrix was markedly enriched in chromium-DNA adducts (approximately 4-fold compared with total nuclear DNA) at this time. As previously demonstrated, chromium-DNA adducts in total nuclear DNA decreased within the first 24 h, but thereafter persisted at a similar level. Chromium-DNA adducts in nuclear matrix DNA also reached maximum levels at the end of the 2 h treatment and decreased to 68% and 39% of this level by 24 and 48 h after treatment respectively. In contrast, the adduct levels in the 1SF and bulk chromatin fractions did not change up to 48 h after treatment. Chromium-induced DNA-protein crosslinks, which were stable to 8 M urea and 2% SDS, occurred almost exclusively in the nuclear matrix fraction. The crosslinks in this fraction reached a maximum level at the end of the 2 h treatment, but returned to control levels 24 h later.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033323     DOI: 10.1093/carcin/15.7.1443

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  16 in total

1.  Mechanisms of chromium-induced suppression of RNA synthesis in cellular and cell-free systems: relationship to RNA polymerase arrest.

Authors:  Jian Xu; Francis C R Manning; Travis J O'Brien; Susan Ceryak; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 2.  Chromium exposure disrupts chromatin architecture upsetting the mechanisms that regulate transcription.

Authors:  Hesbon A Zablon; Andrew VonHandorf; Alvaro Puga
Journal:  Exp Biol Med (Maywood)       Date:  2019-04-01

3.  FANCD2 monoubiquitination and activation by hexavalent chromium [Cr(VI)] exposure: activation is not required for repair of Cr(VI)-induced DSBs.

Authors:  Susan K Vilcheck; Susan Ceryak; Travis J O'Brien; Steven R Patierno
Journal:  Mutat Res       Date:  2006-08-08       Impact factor: 2.433

4.  Long-term Coexposure to Hexavalent Chromium and B[a]P Causes Tissue-Specific Differential Biological Effects in Liver and Gastrointestinal Tract of Mice.

Authors:  Francisco Javier Sánchez-Martín; Yunxia Fan; Vinicius Carreira; Jerald L Ovesen; Andrew Vonhandorf; Ying Xia; Alvaro Puga
Journal:  Toxicol Sci       Date:  2015-03-29       Impact factor: 4.849

5.  Long-term exposure to hexavalent chromium inhibits expression of tumor suppressor genes in cultured cells and in mice.

Authors:  Yunxia Fan; Jerald L Ovesen; Alvaro Puga
Journal:  J Trace Elem Med Biol       Date:  2012-05-19       Impact factor: 3.849

6.  Nucleotide excision repair functions in the removal of chromium-induced DNA damage in mammalian cells.

Authors:  Travis J O'Brien; Bradford R Brooks; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

7.  Differential impact of ionic and coordinate covalent chromium (Cr)-DNA binding on DNA replication.

Authors:  Jamie L Fornsaglio; Travis J O'Brien; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

8.  Resistance to apoptosis, increased growth potential, and altered gene expression in cells that survived genotoxic hexavalent chromium [Cr(VI)] exposure.

Authors:  Daryl E Pritchard; Susan Ceryak; Keri E Ramsey; Travis J O'Brien; Linan Ha; Jamie L Fornsaglio; Dietrich A Stephan; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2005-11       Impact factor: 3.396

9.  Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: lack of effect of ERK.

Authors:  Susan Ceryak; Carla Zingariello; Travis O'Brien; Steven R Patierno
Journal:  Mol Cell Biochem       Date:  2004-01       Impact factor: 3.396

Review 10.  Metals and molecular carcinogenesis.

Authors:  Yusha Zhu; Max Costa
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.